Search

everythinglearnresearchcommunity

for

Search:↓

A woman survived a massive lithium overdose that caused a form of hair loss.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

The hair serum reduced hair loss and improved hair quality in women.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Carbamazepine caused hair loss in a man, which stopped after he stopped taking the drug.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Long-COVID symptoms can last more than a year and change over time.

Hair loss from telogen effluvium may not happen again after another surgery.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Low iron and vitamin D levels are linked to hair loss in women.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

Iron deficiency is linked to hair loss in CTE patients.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.